Logo 1 Logo 2

Clinical Trial Details

Trial ID: L1872
Source ID: NCT03594591
Associated Drug: Antidiabetic Treatment By Usual Care
Title: Changes in the Retinal and Carotid Microcirculation After Restoring Normoglycemia in Patients With Type 2 Diabetes
Acronym: OCTAUS-T2D
Status: UNKNOWN
Study Results: NO
Results:
Conditions: Type 2 Diabetes Mellitus|Microangiopathy|Diabetic Retinopathy|Arteriosclerosis|Carotid Atherosclerosis
Interventions: DRUG: Antidiabetic treatment by usual care
Outcome Measures: Primary: Changes in retinal microcirculation (perifoveal vessel density), Changes in perifoveal vessel density, OCTA images will be processed to obtain vascular density measurements in this area (mm-1), 0, 1, 3 and 6 months|Changes in arterial wall microcirculation (vasa-vasorum density), Changes vasa-vasorum (VV) density, VV signal as the ratio of the contrast agent signal of the VV and that of the lumen of the artery, 0, 3 and 6 months | Secondary: Changes in retinal microcirculation (Parafoveal vessel density ), OCTA images will be processed to obtain vascular density measurements in this area (mm-1), 0, 1, 3 and 6 months|Changes in retinal microcirculation (Total Avascular Area ), OCTA images will be processed to obtain total avascular area measurements (mm2), 0, 1, 3 and 6 months|Changes in retinal microcirculation (Foveal Avascular Area), OCTA images will be processed to obtain foveal avascular zone area measurements (mm2), 0, 1, 3 and 6 months
Sponsor/Collaborators: Sponsor: Hospital Clinic of Barcelona | Collaborators: Instituto de Salud Carlos III|Institut d'Investigacions Biomèdiques August Pi i Sunyer
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases:
Enrollment: 20
Study Type: OBSERVATIONAL
Study Designs: Observational Model: |Time Perspective: p
Start Date: 2018-01-02
Completion Date: 2020-01-01
Results First Posted:
Last Update Posted: 2018-07-24
Locations: Hospital Clínic de Barcelona, Barcelona, 08036, Spain
URL: https://clinicaltrials.gov/show/NCT03594591